ArticleFrontiers in microbiology2016
Rhamnolipid Biosurfactant against
Article in Frontiers in microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed.
- Antifungal activity and mycotoxin-inhibiting potential of amphisin and rhamnolipids from Pseudomonas strains.Scientific reports · 2025Article
- Article
- Review
- Genetic and Genomic Tools in Breeding for Resistance to Fusarium Stalk Rot in Maize (Plants (Basel, Switzerland) · 2025Review
- Rhamnolipids bio-production and miscellaneous applications towards green technologies: a literature review.PeerJ · 2025Review
- A Comprehensive Review on Bioactive Molecules and Advanced Microorganism Management Technologies.Current issues in molecular biology · 2024Review
- Antifungal effect and some properties of cell-free supernatants of two Bacillus subtilis isolates against Fusarium verticillioides.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024Article
- Genomic Insights intoInternational journal of molecular sciences · 2024Article
- Bioformulation ofFrontiers in bioengineering and biotechnology · 2024Article
- Metabolic engineering ofMetabolic engineering communications · 2022Article
- Emulsifying Properties of Rhamnolipids and Their In Vitro Antifungal Activity against Plant Pathogenic Fungi.Molecules (Basel, Switzerland) · 2022Article
- Antimicrobial Compounds from Microorganisms.Antibiotics (Basel, Switzerland) · 2022Review
- Overview on Glycosylated Lipids Produced by Bacteria and Fungi: Rhamno-, Sophoro-, Mannosylerythritol and Cellobiose Lipids.Advances in biochemical engineering/biotechnology · 2022Article
- Rhamnolipids and fengycins, very promising amphiphilic antifungal compounds from bacteria secretomes, act onFrontiers in microbiology · 2022Article
- Antifungal activity of bacterial strains from maize silks against Fusarium verticillioides.Archives of microbiology · 2021Article
- Antiviral Activity of the Rhamnolipids Mixture from the Antarctic BacteriumPharmaceutics · 2021Article
- Foaming of rhamnolipids fermentation: impact factors and fermentation strategies.Microbial cell factories · 2021Review
- Biosurfactant based formulation of Pseudomonas guariconensis LE3 with multifarious plant growth promoting traits controls charcoal rot disease in Helianthus annus.World journal of microbiology & biotechnology · 2021Article
- Application of Environment-Friendly Rhamnolipids against Transmission of Enveloped Viruses Like SARS-CoV2.Viruses · 2021Article
- Seed Endophytic Bacteria of Pearl Millet (Frontiers in microbiology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antifungal activity of rhamnolipids (RLs) has been widely studied against many plant pathogenic fungi, but not against
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.